HemoHIM

02/01/2010 - "HemoHIM enhances the therapeutic efficacy of ionizing radiation treatment in tumor-bearing mice."
02/01/2014 - "We propose HemoHIM as a beneficial supplement drug during radiotherapy to alleviate adverse radiation-induced effects for cancer patients."
02/01/2010 - "IR treatment (5 Gy at 7 days after melanoma cell injection) reduced the weight of the solid tumors, and HemoHIM supplementation with IR enhanced the decreases in tumor weight (P < .03). "
03/17/2009 - "Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice."
03/17/2009 - "HemoHIM may be a beneficial supplement during cisplatin chemotherapy for enhancing the anti-tumor efficacy and reducing the toxicity of cisplatin."

02/01/2010 - "In this study, we examined the possibility that HemoHIM can enhance the anticancer effects of ionizing radiation (IR) in melanoma-bearing mice. "
02/01/2010 - "In the melanoma-bearing mice treated with IR, HemoHIM administration also increased the activity of natural killer cells and cytotoxic T cells, although the proportions of these cells in spleen were not different. "
02/01/2010 - "Anticancer effects of HemoHIM were evaluated in melanoma-bearing mice exposed to IR. "
02/01/2010 - "IR treatment (5 Gy at 7 days after melanoma cell injection) reduced the weight of the solid tumors, and HemoHIM supplementation with IR enhanced the decreases in tumor weight (P < .03). "
03/17/2009 - "In this study, we examined the possibility of HemoHIM both to enhance anticancer effect with cisplatin and to reduce the side effects of cisplatin in melanoma-bearing mice. "

12/01/2019 - "To date, studies on the protective effects of HemoHIM against gastritis and gastric ulcers have not been conducted. "
12/01/2019 - "Discussion and conclusions: Based on the results, HemoHIM is potential candidate for the treatment of gastritis and gastric ulcers."

01/01/2014 - "This study determined whether or not HemoHIM could alter hyperglycemia and the immune response in diabetic mice. "
01/01/2014 - "In diabetic mice, HemoHIM effectively improved hyperglycemia and glucose tolerance compared to the diabetic control group as well as elevated plasma insulin levels with preservation of insulin staining in pancreatic β-cells. "

12/01/2019 - "To date, studies on the protective effects of HemoHIM against gastritis and gastric ulcers have not been conducted. "
12/01/2019 - "Discussion and conclusions: Based on the results, HemoHIM is potential candidate for the treatment of gastritis and gastric ulcers."